Topic 02 / 07
Regulation in Japan
Japan regulates regenerative medicine under the Act on the Safety of Regenerative Medicine. This topic covers the legal framework, the risk classes, provision plans and review committees, and recent amendments.
01What this topic covers
- The Act on the Safety of Regenerative Medicine
- Class I, Class II and Class III
- Provision plans and review committees
- The 2025 amendment
- The MHLW information and reporting window
02Three things to know first
- November 2014: Japan’s Act on the Safety of Regenerative Medicine took effect.
- Before treatment, a medical institution must prepare a “provision plan for regenerative medicine”, have it reviewed by a certified committee and submit it to the MHLW; offering treatment without doing so is illegal.
- Three classes: Class I (high risk), Class II (medium risk), Class III (low risk).
Source: Ministry of Health, Labour and Welfare (MHLW), "再生医療・細胞医療・遺伝子治療について" (Regenerative, cell and gene therapy); checked 2026-11 · Read the full regulation guide
03Guides in this topic
Regulation in JapanHow Stem Cells Are Cultured for Treatment in Japan: CPCs, Serum-Free Media and Fresh vs Frozen CellsWhere Japan grows stem cells for treatment: registered cell processing facilities, facility and plan numbers, serum-free media, fresh vs frozen cells and release tests.
Regulation in JapanWhere Japan's Regenerative Medicine Clinics Are: Tokyo, Osaka and the MHLW RegisterJapan's MHLW register lists about 4,464 providers of regenerative treatment. Tokyo holds a third and Osaka ranks second. Here are the numbers and what to check.
Regulation in JapanWhy Japanese Clinics Can't Show Before-and-After Photos: Japan's Medical Advertising RulesJapan bans patient testimonials and misleading before-and-after photos in clinic ads. What the law and MHLW guidelines require, and how to read a clinic site.
Regulation in JapanHow to Tell Whether a Japanese Regenerative Medicine Clinic Is CompliantA Japanese regenerative clinic is compliant only if your specific treatment has a filed plan, a matching risk class and committee, and written consent.
Regulation in JapanRegenerative Medicine in Japan: How the Safety Act Works and the Three Risk ClassesHow Japan's Act on the Safety of Regenerative Medicine works: the three risk classes, the two review committees, the 90-day Class I wait and reporting duties.
Regulation in JapanStem Cell Therapy in Japan vs Mexico, Panama, Korea and Thailand: How the Rules DifferWho regulates stem cell therapy in Japan, Korea, Thailand, Mexico and Panama, what each country lets clinics offer, and what to ask before you choose.
Regulation in JapanWhich Stem Cell Treatments Are FDA-Approved, and How Japan's System DiffersWhich stem cell and cell therapies the FDA licenses, what it says about unapproved products, and how Japan's Safety Act differs from US licensing.
Regulation in JapanWhy Regenerative Treatment in Japan Is Self-Pay: Private Medical Care and Insurance ExplainedMost clinic regenerative treatments in Japan are self-pay private care. Learn how insured care differs, why mixing is limited, and what approval changes.
04Other topics
The information on this site is general information and is not medical advice; whether any therapy suits you can only be decided by a doctor after an in-person consultation.